Senti Biosciences (SNTI) Live Share Price, Invest From India

Senti Biosciences Stock Performance

as on October 7, 2026 at 6:59 am IST

Day's Low
Day's High
$0.31
Day's Price Range
$0.34
$0.31
0.64%
Downside
8.97%
Upside
52 Week's Low
52 Week's High
$0.29
52-Week Price Range
$2.88
$0.31
7.05%
Downside
823.08%
Upside

Senti Biosciences share price movements today

Previous Close: $0.35
Open: $0.33
Volume: 613.0K
Market Cap: $10.0M
Day's Low - High: $0.31 - $0.34
52 Week Low - High: $0.29 - $2.88

Senti Biosciences Historical Returns

1 Month Return: + 3.76 %
3 Month Return: -68.05 %
1 Year Return: -79.34 %
3 Year Return: -90.52 %
5 Year Return: 0 %

Senti Biosciences Stock Fundamentals & Key Indicators

Check Senti Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.0M

EPS (TTM)

-1.77

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.18

Industry PE ratio

-3.20

PEG Ratio

-0.00

EBITDA

-47.2M

Revenue (TTM)

55.0K

Profit Margin

-2736.36%

Return On Equity TTM

-1539.97%

Senti Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Senti Biosciences with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Senti Biosciences	Buy	$10.0M	NA	-0.18	-2736.36%	0.00%
Revolution Medicines	StrongBuy	$44.3B	650.56%	-23.32	0.00%	0.00%
Moderna	Neutral	$75.9B	-32.81%	-23.81	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$127.9B	178.32%	29.14	86.04%	0.00%
Regeneron	Buy	$75.7B	32.91%	17.55	84.86%	0.50%

Stock Returns calculator for Senti Biosciences Stock including INR - Dollar returns

The Senti Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Senti Biosciences investment value today

Current value as on today

₹20,304

Returns

-₹79,696

(-79.7%)

Returns from Senti Biosciences Stock

-₹81,317 (-81.32%)

Dollar Impact

₹1,621 (+1.62%)

Analyst Recommendation on Senti Biosciences Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Senti Biosciences. Average target price of $13.5

Senti Biosciences Share Price Target

Get share price movements and forecasts by analysts on Senti Biosciences.

What analysts predicted

97.69%UPSIDE

Target Price

$13.5

Current Price

$0.312

Analyzed by

7 Analysts

Target

$13.50

Senti Biosciences target price $13.5, a slight upside of 97.69% compared to current price of $0.312. According to 7 analysts rating.

Indian Investors' Interest in Senti Biosciences Stock

Search interest for Senti Biosciences Stock has increased by 117% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 7, 2026 to October 7, 2026

Change:117% versus previous 30 day period

Senti Biosciences Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	0	0	0
Gross Profit	-1	-1	-	-1	-	-1	-	0	0	0
Operating Income	-16	-13	-15	-16	-16	-16	-16	-13	-11	-14
EBITDA	-10	-9	-14	0	-15	-13	-16	-13	-3	-13
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	1	1	0	1	0	1	0	0	0	0
Income Before Tax	-12	-11	-28	0	-14	-14	-18	-14	-4	-12
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-12	-11	-28	0	-14	-14	-18	-14	-4	-12
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-3959.09%	100.00%	-3823.53%

Senti Biosciences Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	2	3	1	-	0
Gross Profit	-14	0	2	3	1	-	-3
Operating Income	-21	-24	-40	-62	-92	-61	-63
EBITDA	-21	-22	-52	-45	-61	-54	-57
Interest Expense	-	-	-	-	-	-	-
Depreciation	0	1	3	3	5	5	3
Income Before Tax	-21	-19	-55	-49	-83	-52	-61
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-21	-19	-55	-58	-71	-52	-61
Net Profit Margin	-16987.06%	100.00%	100.00%	100.00%	100.00%	0.00%	-16431.82%

Senti Biosciences Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-12	-11	-28	0	-14	-14	-18	-14	-4	-12
Operating Cash Flow	-11	-8	-7	-13	-14	-13	-9	-6	-7	-14
Investing Cash Flow	0	-	0	0	-	0	-	0	0	-
Financing Cash Flow	-	-	2	51	0	1	0	11	0	9
Change in Cash	-11	-8	-5	37	-14	-12	-9	4	-7	-4

Senti Biosciences Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-21	-19	-55	-58	-71	-52	-61
Operating Cash Flow	-18	-24	-34	-34	-52	-41	-43
Investing Cash Flow	3	11	-5	-81	30	0	0
Financing Cash Flow	14	38	68	118	0	53	11
Change in Cash	5	25	28	1	-21	12	-31

Global Institutional Holdings in Senti Biosciences

Check out the Institutions with significant holdings in Senti Biosciences.

Funds	Holdings
Vanguard	1.73%
Fidelity Concord Street Trust	0.45%
Victory Portfolios III	0.01%

Insights on Senti Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, SNTI stock has moved up by 12.2%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 16.0K → 17.0K (in $), with an average increase of 5.9% per quarter
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 637.9% return, outperforming this stock by 717.2%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 95.6% return, outperforming this stock by 186.1%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -4.22M → -12.75M (in $), with an average decrease of 202.1% per quarter

About Senti Biosciences

Senti Biosciences, Inc. is a pioneering company specializing in gene circuit technology. They focus on creating advanced cell and gene therapies that incorporate sophisticated gene circuits, essentially biological computers, to genetically reprogram cells. This allows the modified cells to interpret biological cues, make precise decisions, and react appropriately within their specific cellular surroundings. Their proprietary synthetic biology platform leverages readily available, "off-the-shelf" chimeric antigen receptor natural killer (CAR-NK) cells. This innovative approach is specifically designed to tackle formidable liquid and solid tumor cancers. Among their leading therapeutic candidates is SENTI-202. This "Logic Gated OR+NOT" off-the-shelf CAR-NK cell therapy is engineered to selectively identify and destroy acute myeloid leukemia (AML) cells, critically leaving healthy bone marrow unharmed. Another key program, SENTI-301, is a multi-armed, ready-to-use CAR-NK cell therapy being developed for the treatment of hepatocellular carcinoma (HCC). Additionally, SENTI-401, a Logic Gated (NOT) off-the-shelf CAR-NK cell therapy, aims to precisely eliminate colorectal cancer (CRC) cells without damaging the body's healthy tissues. Established in 2016, Senti Biosciences maintains its headquarters in South San Francisco, California.

Organisation	Senti Biosciences
Headquarters	2 Corporate Drive, South San Francisco, CA, 94080, US
Industry	Biotechnology
CEO	Timothy K. Lu

Key Management of Senti Biosciences

Name	Title
Mr. Faraz Siddiqui	Senior Vice President of Technical Operations
Mr. Robert H. Cutler J.D.	Senior VP & Head of Legal Affairs
Mr. Thomas P. Chung	Vice President of Strategic Finance & Corporate Development
Dr. Timothy K. Lu M.D., Ph.D.	Co-Founder, CEO & Director
Dr. Kanya Rajangam M.D., Ph.D.	President, Head of Research & Development and Chief Medical Officer
Dr. James J. Collins Ph.D.	Scientific Co-Founder, Chairperson of Scientific Advisory Board & Independent Director
Mr. Jay Cross	Chief Financial Officer
Dr. Wilson Wong Ph.D.	Scientific Co-Founder & Member of Scientific Advisory Board

FAQs

What is Senti Biosciences share price today?

Senti Biosciences share price today is $0.31 as on October 7, 2026 at 1:29 am IST at the close of the market. Senti Biosciences share today touched a day high of $0.34 and a low of $0.31.

What is the 52 week high and 52 week low for Senti Biosciences share?

Senti Biosciences share touched a 52 week high of $2.88 on December 9, 2025 and a 52 week low of $0.29 on September 9, 2026. Senti Biosciences stock price today i.e. October 7, 2026 at 1:29 am IST is closed at $0.31,which is 89.17% down from its 52 week high and 7.59% up from its 52 week low.

What is Senti Biosciences's market capitalisation today?

Senti Biosciences market capitalisation is $0.00T as on October 7, 2026 at 1:29 am IST.

How to invest in Senti Biosciences Stock (SNTI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Senti Biosciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Senti Biosciences Stock (SNTI) from India?

Indian investors can start investing in Senti Biosciences (SNTI) shares with as little as ₹96.419998168945 or $1 (as of October 7, 2026 at 5:45 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹964.20 in Senti Biosciences stock (as per the Rupee-Dollar exchange rate as on October 7, 2026 at 5:45 am IST). Based on Senti Biosciences share’s latest price of $0.31 as on October 7, 2026 at 1:29 am IST, you will get 32.0513 shares of Senti Biosciences. Learn more about fractional shares .